Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of David Brandon Bowen
Introduction: David Brandon Bowen is a notable inventor based in Macclesfield, GB, primarily recognized for his inventive contributions in the pharmaceutical field. With a significant focus on enhancing the stability and shelf-life of pharmaceutical compositions, Bowen has made an impactful mark in the industry.
Latest Patents: Bowen holds a patent for "Lisinopril compositions having large-particle DCPD." This invention relates to a pharmaceutical composition that includes lisinopril and dibasic calcium phosphate dihydrate (DCPD). The unique aspect of this invention lies in its manufacturing process, which involves mixing lisinopril with DCPD that has a specific surface area of less than 1.5 m²/g. The use of larger particle-sized DCPD significantly reduces the formation of the lisinopril degradation product DKP, thus increasing the shelf-life of tablets formulated with this composition. Such innovations, particularly for low doses of lisinopril, demonstrate Bowen's commitment to enhancing pharmaceutical formulations.
Career Highlights: David Bowen is associated with AstraZeneca AB, a renowned global biopharmaceutical company where he focuses on research and development in the fields of pharmaceuticals. His dedication to enhancing drug formulations has driven advancements in the industry, ensuring that patients receive effective and stable medication.
Collaborations: Throughout his career, Bowen has collaborated with esteemed professionals in the pharmaceutical sector, including his coworker Ronald John Roberts. Such collaborations have helped propel his research forward, fostering an environment of innovation and shared knowledge in the development of improved pharmaceutical compositions.
Conclusion: With his patent on lisinopril compositions utilizing large-particle DCPD, David Brandon Bowen exemplifies the spirit of innovation in the pharmaceutical industry. His work at AstraZeneca AB, alongside collaboration with industry experts, showcases the importance of continuous improvement in drug formulations. Through his contributions, Bowen has significantly impacted the quality and longevity of pharmaceutical products on the market today.